CDNA - CareDx, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
CareDx, Inc.
CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime.
IPO Date: July 17, 2014
Sector: Healthcare
Industry: Diagnostics and Research
Market Cap: $3.22B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.69 | 3.33%
Avg Daily Range (30 D): $1.52 | 2.61%
Avg Daily Range (90 D): $1.26 | 3.11%
Institutional Daily Volume
Avg Daily Volume: .54M
Avg Daily Volume (30 D): 1.13M
Avg Daily Volume (90 D): .94M
Trade Size
Avg Trade Size (Sh.): 74
Avg Trade Size (Sh.) (30 D): 53
Avg Trade Size (Sh.) (90 D): 56
Institutional Trades
Total Institutional Trades: 3,885
Avg Institutional Trade: $2.39M
Avg Institutional Trade (30 D): $4.29M
Avg Institutional Trade (90 D): $4.01M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.02M
Avg Closing Trade (30 D): $10.75M
Avg Closing Trade (90 D): $7.63M
Avg Closing Volume: 120.71K
 
News
Oct 5, 2026 @ 10:45 AM
Immunogenomics Market Size, Share, Trends, and Gro...
Source: Researchandmarkets.Com
Sep 30, 2026 @ 11:29 AM
Consumer Confidence Falls Amid Ongoing Geopolitica...
Source: Zacks.Com
Sep 14, 2026 @ 12:45 PM
4 Healthcare Stocks to Play Safe as Fed Gears Up f...
Source: Na
Sep 9, 2026 @ 12:41 PM
Oil Surge Continues on Escalating Middle East Cris...
Source: Zacks.Com
Jul 31, 2026 @ 9:24 PM
Why CareDx Stock Jumped Today
Source: Joe Tenebruso
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $2.16 $2.15 $.05
Diluted EPS $2.08 $2.07 $.05
Revenue $458.09M $131.95M $117.7M
Gross Profit
Net Income / Loss $111.01M $110.64M $2.81M
Operating Income / Loss $108.14M $113.22M $1.2M
Cost of Revenue
Net Cash Flow $305.39M $295.69M $12.48M
PE Ratio